These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Increase in beta-lactam-resistant Proteus mirabilis strains due to CTX-M- and CMY-type as well as new VEB- and inhibitor-resistant TEM-type beta-lactamases. Aragón LM, Mirelis B, Miró E, Mata C, Gómez L, Rivera A, Coll P, Navarro F. J Antimicrob Chemother; 2008 May; 61(5):1029-32. PubMed ID: 18292096 [Abstract] [Full Text] [Related]
4. Emergence of multidrug-resistant Proteus mirabilis in a long-term care facility in Croatia. Bedenić B, Firis N, Elveđi-Gašparović V, Krilanović M, Matanović K, Štimac I, Luxner J, Vraneš J, Meštrović T, Zarfel G, Grisold A. Wien Klin Wochenschr; 2016 Jun; 128(11-12):404-13. PubMed ID: 27220339 [Abstract] [Full Text] [Related]
11. Spread of extended-spectrum beta-lactamase CTX-M-producing escherichia coli clinical isolates in community and nosocomial environments in Portugal. Mendonça N, Leitão J, Manageiro V, Ferreira E, Caniça M. Antimicrob Agents Chemother; 2007 Jun; 51(6):1946-55. PubMed ID: 17371815 [Abstract] [Full Text] [Related]
13. Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Jarlier V, Nicolas MH, Fournier G, Philippon A. Rev Infect Dis; 1988 Feb; 10(4):867-78. PubMed ID: 3263690 [Abstract] [Full Text] [Related]
14. Interspecies spread of CTX-M-32 extended-spectrum beta-lactamase and the role of the insertion sequence IS1 in down-regulating bla CTX-M gene expression. Fernández A, Gil E, Cartelle M, Pérez A, Beceiro A, Mallo S, Tomás MM, Pérez-Llarena FJ, Villanueva R, Bou G. J Antimicrob Chemother; 2007 May; 59(5):841-7. PubMed ID: 17332005 [Abstract] [Full Text] [Related]